137 related articles for article (PubMed ID: 32988145)
21. High levels of Tim-3
Zhong W; Liu X; Zhu Z; Li Q; Li K
Int Immunopharmacol; 2021 Jul; 96():107662. PubMed ID: 33864956
[TBL] [Abstract][Full Text] [Related]
22. PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors.
Wang JJ; Burger P; Taube J; Soni A; Chaichana K; Sheu M; Belcaid Z; Jackson C; Lim M
Cureus; 2019 Dec; 11(12):e6352. PubMed ID: 31938638
[TBL] [Abstract][Full Text] [Related]
23. Non-neoplastic cells as prognostic biomarkers in diffuse large B-cell lymphoma: A system review and meta-analysis.
Zhao M; Wang L; Wang X; He J; Yu K; Li D
Tumori; 2024 Jan; ():3008916231221636. PubMed ID: 38183180
[TBL] [Abstract][Full Text] [Related]
24. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
25. The prognostic and clinicopathological significance of Tim-3 and PD-1 expression in the prognosis of upper urinary tract urothelial carcinoma.
Chen H; Wang M; Weng T; Wei Y; Liu C; Yang L; Ren K; Tang Y; Tang Z; Gou X
Urol Oncol; 2021 Nov; 39(11):743-753. PubMed ID: 34330653
[TBL] [Abstract][Full Text] [Related]
26. Characterization of TIM-3 expression and its prognostic value in patients with surgically resected lung adenocarcinoma.
Su H; Xie H; Dai C; Ren Y; She Y; Xu L; Chen D; Xie D; Zhang L; Jiang G; Chen C
Lung Cancer; 2018 Jul; 121():18-24. PubMed ID: 29858021
[TBL] [Abstract][Full Text] [Related]
27. Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer.
Chevalier MF; Bohner P; Pieraerts C; Lhermitte B; Gourmaud J; Nobile A; Rotman S; Cesson V; Martin V; Legris AS; Dartiguenave F; Gharbi D; De Leval L; Speiser DE; Nardelli-Haefliger D; Jichlinski P; Derré L
Eur Urol; 2017 Jun; 71(6):854-857. PubMed ID: 28277277
[TBL] [Abstract][Full Text] [Related]
28. Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma.
Imai Y; Hasegawa K; Matsushita H; Fujieda N; Sato S; Miyagi E; Kakimi K; Fujiwara K
Oncol Lett; 2018 May; 15(5):6457-6468. PubMed ID: 29616115
[TBL] [Abstract][Full Text] [Related]
29. Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors.
Natoli M; Hatje K; Gulati P; Junker F; Herzig P; Jiang Z; Davydov II; Germann M; Trüb M; Marbach D; Zwick A; Weber P; Seeber S; Wiese M; Lardinois D; Heinzelmann-Schwarz V; Rosenberg R; Tietze L; Mertz KD; Umaña P; Klein C; Codarri-Deak L; Kao H; Zippelius A
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36319064
[TBL] [Abstract][Full Text] [Related]
30. The immune checkpoint expression in the tumor immune microenvironment of DLBCL: Clinicopathologic features and prognosis.
Ma J; Pang X; Li J; Zhang W; Cui W
Front Oncol; 2022; 12():1069378. PubMed ID: 36561512
[TBL] [Abstract][Full Text] [Related]
31. Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
Hu LY; Xu XL; Rao HL; Chen J; Lai RC; Huang HQ; Jiang WQ; Lin TY; Xia ZJ; Cai QQ
Chin J Cancer; 2017 Dec; 36(1):94. PubMed ID: 29246182
[TBL] [Abstract][Full Text] [Related]
32. Significance of TIM-3 Expression in Resected Esophageal Squamous Cell Carcinoma.
Zhao Y; Chen D; Wang W; Zhao T; Wen J; Zhang F; Duan S; Chen C; Sang Y; Zhang Y; Chen Y
Ann Thorac Surg; 2020 May; 109(5):1551-1557. PubMed ID: 31987829
[TBL] [Abstract][Full Text] [Related]
33. Tim-3 expression is increased on peripheral T cells from diffuse large B cell lymphoma.
Xiao T; Zhang L; Chen L; Liu G; Feng Z; Gao L
Tumour Biol; 2014 Aug; 35(8):7951-6. PubMed ID: 24833097
[TBL] [Abstract][Full Text] [Related]
34. PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients.
Denize T; Jegede OA; Matar S; El Ahmar N; West DJ; Walton E; Bagheri AS; Savla V; Nabil Laimon Y; Gupta S; Vemula SV; Braun DA; Burke KP; Catalano PJ; Freeman GJ; Motzer RJ; Atkins MB; McDermott DF; Sharpe AH; Choueiri TK; Signoretti S
Clin Cancer Res; 2024 Feb; 30(4):803-813. PubMed ID: 38060202
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer.
Kuai W; Xu X; Yan J; Zhao W; Li Y; Wang B; Yuan N; Li Z; Jia Y
Biomed Res Int; 2020; 2020():5294043. PubMed ID: 32509862
[TBL] [Abstract][Full Text] [Related]
36. Increased exhausted CD8
Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes.
Wang J; Gao K; Lei W; Dong L; Xuan Q; Feng M; Wang J; Ye X; Jin T; Zhang Z; Zhang Q
Oncotarget; 2017 Jan; 8(3):5414-5425. PubMed ID: 28036275
[TBL] [Abstract][Full Text] [Related]
38. [A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].
Wang X; Xia B; Wang CY; Li MZ; Xu W; Yuan T; Tian C; Zhao HF; Yang HL; Zhao ZG; Wang XF; Wang YF; Yu Y; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):117-124. PubMed ID: 30831626
[No Abstract] [Full Text] [Related]
39. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.
Tao R; Wang L; Han R; Wang T; Ye Q; Honjo T; Murphy TL; Murphy KM; Hancock WW
J Immunol; 2005 Nov; 175(9):5774-82. PubMed ID: 16237069
[TBL] [Abstract][Full Text] [Related]
40. PD-1 expression on the surface of peripheral blood CD4
Zhang W; Bai JF; Zuo MX; Cao XX; Chen M; Zhang Y; Han X; Zhong DR; Zhou DB
Cancer Med; 2016 Nov; 5(11):3077-3084. PubMed ID: 27709793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
